Your browser doesn't support javascript.
loading
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients.
Pogliaghi, Manuela; Papagno, Laura; Lambert, Sidonie; Calin, Ruxandra; Calvez, Vincent; Katlama, Christine; Autran, Brigitte.
Affiliation
  • Pogliaghi M; aUPMC Univ Paris 06, UMR-S945 bInserm, U945, Laboratory of Immunity and Infection, Paris, France cUniversità Vita-Salute, San Raffaele Scientific Institute, Milan, Italy dORVACS, Hospital Pitié-Salpêtrière eUPMC Univ Paris 06, UMR-S943, Epidemiology, Therapeutics Strategies and Clinical Virology in HIV Infection, Paris, France fInserm, U943, Epidemiology, Therapeutics Strategies and Clinical Virology in HIV Infection gAP-HP, Hospital Pitié-Salpêtrière Hospital, Department of Virology hAP-HP, Hos
AIDS ; 28(2): 278-81, 2014 Jan 14.
Article in En | MEDLINE | ID: mdl-24361684
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Thiazoles / Virus Replication / CD4-Positive T-Lymphocytes / HIV-1 / Anti-HIV Agents Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2014 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Thiazoles / Virus Replication / CD4-Positive T-Lymphocytes / HIV-1 / Anti-HIV Agents Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2014 Document type: Article Country of publication: